Cargando…
Su1189 SAFETY OF IMMUNE CHECKPOINT INHIBITORS IN PATIENTS WITH PREEXISTING INFLAMMATORY BOWEL DISEASE AND MICROSCOPIC COLITIS
| Autores principales: | , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
AGA Institute. Published by Elsevier Inc.
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7237173/ http://dx.doi.org/10.1016/S0016-5085(20)32037-0 |
| _version_ | 1783536273557815296 |
|---|---|
| author | Grover, Shilpa Ruan, Alex Srivoleti, Padma Giobbie-Hurder, Anita Braschi-Amirfarzan, Marta Srivastava, Amitabh Buchbinder, Elizabeth Ott, Patrick Hodi, F. Stephen Kehl, Kenneth Awad, Mark Rahma, Osama |
| author_facet | Grover, Shilpa Ruan, Alex Srivoleti, Padma Giobbie-Hurder, Anita Braschi-Amirfarzan, Marta Srivastava, Amitabh Buchbinder, Elizabeth Ott, Patrick Hodi, F. Stephen Kehl, Kenneth Awad, Mark Rahma, Osama |
| author_sort | Grover, Shilpa |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7237173 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | AGA Institute. Published by Elsevier Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-72371732020-05-20 Su1189 SAFETY OF IMMUNE CHECKPOINT INHIBITORS IN PATIENTS WITH PREEXISTING INFLAMMATORY BOWEL DISEASE AND MICROSCOPIC COLITIS Grover, Shilpa Ruan, Alex Srivoleti, Padma Giobbie-Hurder, Anita Braschi-Amirfarzan, Marta Srivastava, Amitabh Buchbinder, Elizabeth Ott, Patrick Hodi, F. Stephen Kehl, Kenneth Awad, Mark Rahma, Osama Gastroenterology AGA Abstracts AGA Institute. Published by Elsevier Inc. 2020-05 2020-05-19 /pmc/articles/PMC7237173/ http://dx.doi.org/10.1016/S0016-5085(20)32037-0 Text en Copyright © 2020 AGA Institute. Published by Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | AGA Abstracts Grover, Shilpa Ruan, Alex Srivoleti, Padma Giobbie-Hurder, Anita Braschi-Amirfarzan, Marta Srivastava, Amitabh Buchbinder, Elizabeth Ott, Patrick Hodi, F. Stephen Kehl, Kenneth Awad, Mark Rahma, Osama Su1189 SAFETY OF IMMUNE CHECKPOINT INHIBITORS IN PATIENTS WITH PREEXISTING INFLAMMATORY BOWEL DISEASE AND MICROSCOPIC COLITIS |
| title | Su1189 SAFETY OF IMMUNE CHECKPOINT INHIBITORS IN PATIENTS WITH PREEXISTING INFLAMMATORY BOWEL DISEASE AND MICROSCOPIC COLITIS |
| title_full | Su1189 SAFETY OF IMMUNE CHECKPOINT INHIBITORS IN PATIENTS WITH PREEXISTING INFLAMMATORY BOWEL DISEASE AND MICROSCOPIC COLITIS |
| title_fullStr | Su1189 SAFETY OF IMMUNE CHECKPOINT INHIBITORS IN PATIENTS WITH PREEXISTING INFLAMMATORY BOWEL DISEASE AND MICROSCOPIC COLITIS |
| title_full_unstemmed | Su1189 SAFETY OF IMMUNE CHECKPOINT INHIBITORS IN PATIENTS WITH PREEXISTING INFLAMMATORY BOWEL DISEASE AND MICROSCOPIC COLITIS |
| title_short | Su1189 SAFETY OF IMMUNE CHECKPOINT INHIBITORS IN PATIENTS WITH PREEXISTING INFLAMMATORY BOWEL DISEASE AND MICROSCOPIC COLITIS |
| title_sort | su1189 safety of immune checkpoint inhibitors in patients with preexisting inflammatory bowel disease and microscopic colitis |
| topic | AGA Abstracts |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7237173/ http://dx.doi.org/10.1016/S0016-5085(20)32037-0 |
| work_keys_str_mv | AT grovershilpa su1189safetyofimmunecheckpointinhibitorsinpatientswithpreexistinginflammatoryboweldiseaseandmicroscopiccolitis AT ruanalex su1189safetyofimmunecheckpointinhibitorsinpatientswithpreexistinginflammatoryboweldiseaseandmicroscopiccolitis AT srivoletipadma su1189safetyofimmunecheckpointinhibitorsinpatientswithpreexistinginflammatoryboweldiseaseandmicroscopiccolitis AT giobbiehurderanita su1189safetyofimmunecheckpointinhibitorsinpatientswithpreexistinginflammatoryboweldiseaseandmicroscopiccolitis AT braschiamirfarzanmarta su1189safetyofimmunecheckpointinhibitorsinpatientswithpreexistinginflammatoryboweldiseaseandmicroscopiccolitis AT srivastavaamitabh su1189safetyofimmunecheckpointinhibitorsinpatientswithpreexistinginflammatoryboweldiseaseandmicroscopiccolitis AT buchbinderelizabeth su1189safetyofimmunecheckpointinhibitorsinpatientswithpreexistinginflammatoryboweldiseaseandmicroscopiccolitis AT ottpatrick su1189safetyofimmunecheckpointinhibitorsinpatientswithpreexistinginflammatoryboweldiseaseandmicroscopiccolitis AT hodifstephen su1189safetyofimmunecheckpointinhibitorsinpatientswithpreexistinginflammatoryboweldiseaseandmicroscopiccolitis AT kehlkenneth su1189safetyofimmunecheckpointinhibitorsinpatientswithpreexistinginflammatoryboweldiseaseandmicroscopiccolitis AT awadmark su1189safetyofimmunecheckpointinhibitorsinpatientswithpreexistinginflammatoryboweldiseaseandmicroscopiccolitis AT rahmaosama su1189safetyofimmunecheckpointinhibitorsinpatientswithpreexistinginflammatoryboweldiseaseandmicroscopiccolitis |